Abstract
OBJECTIVE: To describe the clinical features of patients diagnosed with upper respiratory tract infections (URIs), and determine which clinical features are associated with antibiotic use.
DESIGN: Prospective cohort study.
SETTING: Three ambulatory care practices at a group-model HMO in the Denver metropolitan area.
PATIENTS: Adults (aged 18 years or older) seeking care for acute respiratory illnesses.
MEASUREMENTS: Clinical features were documented on standardized encounter forms. Clinician type, secondary diagnoses, and antibiotic treatment were extracted from administrative databases. Results are presented as adjusted odds ratios (ORs) with 95% confidence intervals (CIs).
MAIN RESULTS: Antibiotics were prescribed to 33% (95% CI 28%, 38%) of patients diagnosed with URI, after excluding patients with coexisting antibiotic-responsive conditions (e.g., sinusitis, pharyngitis) or a history of cardiopulmonary disease. Multivariate logistic regression analysis identified tobacco use (OR 2.8; 95% CI 1.5, 5.1), history of purulent nasal discharge (OR 2.0; 95% CI 1.1, 3.6) or green phlegm (OR 4.8; 95% CI 2.1, 11.1), and examination findings of purulent nasal discharge (OR 5.2; 95% CI 2.4, 11.2) or tonsillar exudate (OR 3.7; 95% CI 1.1, 12.1) to be independently associated with antibiotic use. The majority of patients treated with antibiotics (82%) had at least one of these factors present.
CONCLUSIONS: Antibiotic treatment of URIs is most common when purulent manifestations are present. Efforts to reduce antibiotic treatment of URIs should educate clinicians about the limited value of purulent manifestations in predicting antibiotic-responsive disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Evans AS. Clinical syndromes in adults caused by respiratory infection. Med Clin North Am. 1967;51:803–29.
Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1995. National Center for Health Statistics. Vital Health Stat 13. 1997;129.
Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory infections and bronchitis by ambulatory physicians in the United States. JAMA. 1997;278:901–4.
Mainous AG III, Hueston WJ, Clark JR. Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? J Fam Pract. 1996;42:357–61.
McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214–9.
Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA. 1997;278:944–5. Editorial.
Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract. 1996;43:56–62.
Palmer DA, Bauchner HR. Parents’ and physicians’ views on antibiotics. Pediatrics. 1997;99:E6.
Gonzales R, Crane LA, Barrett PH Jr, Steiner JF. The clinical encounter for acute bronchitis: factors associated with antibiotic use. J Gen Intern Med. 1998;13:541–8.
McKay DN. Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med. 1996;11:557–62.
DeMelker RA, Kuyvenhoven MM. Management of upper respiratory tract infections in Dutch family practice. J Fam Pract. 1994;38:353–7.
Hope-Simpson RE, Miller DL. The definition of acute respiratory illnesses in general practice. Postgrad Med J. 1973;49:763–70.
Mainous AG III, Hueston WJ, Eberlein C. Colour of respiratory discharge and antibiotic use. Lancet. 1997;350:1077.
Mainous AG III, Zoorob RJ, Oler MJ, Haynes DM. Patient knowledge of upper respiratory infections: implications for antibiotic expectations and unnecessary utilization. J Fam Pract. 1997;45:75–83.
Brett AS, Mathieu AE. Perceptions and behaviors of patients with upper respiratory tract infections. J Fam Pract. 1982:15:277–9.
Hutchinson JM, Foley RN. Influence of nonmedical factors on antibiotic prescription rates. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ont., Canada, September 28, 1997.
Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet. 1996;347:1507–10.
Hays GC, Mullard JE, Can nasal bacterial flora be predicted from clinical findings? Pediatrics. 1973;49:596–9.
Robertson AJ. Green sputum. Lancet. 1952:1:12–5.
Heald A, Auckenthaler R, Borst F, et al. Adult bacterial nasopharyngitis: a clinical entity? J Gen Intern Med. 1993;8:667–73.
Walsh TB, Bookheim WW, Johnson RC, Tompkins RK. Recognition of streptococcal pharyngitis in adults. Arch Intern Med. 1975;135:1493–7.
Todd JK, Todd N, Damato J, Todd WA. Bacteriology and treatment of purulent nasopharyngitis: a double blind, placebo-controlled evaluation. Pediatr Infect Dis J. 1984;3:226–32.
Stott NCH, West RR. Randomised controlled trial of antibiotics in patients with cough and purulent sputum. BMJ. 1976;2:556–9.
Verheij TJM, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract. 1994;44:400–4.
Author information
Authors and Affiliations
Additional information
This work was supported in part by a National Research Service Award (5 T32 PE10006) and a Robert Wood Johnson Minority Medical Faculty Development Program Grant (2532434) to Dr. Gonzales, and a Kaiser Permanente of Colorado Research and Development Grant to Drs. Gonzales and Barrett.
Rights and permissions
About this article
Cite this article
Gonzales, R., Barrett, P.H. & Steiner, J.F. The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections. J GEN INTERN MED 14, 151–156 (1999). https://doi.org/10.1046/j.1525-1497.1999.00306.x
Published:
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.1999.00306.x